CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference

VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by MannKind Corporation (Nasdaq: MNKD) (TASE: MNKD), please note that in the first paragraph the date of the presentation should be Thursday, January 12, 2017, not today as previously stated. The corrected release follows:

MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference

MannKind Corporation (Nasdaq: MNKD) (TASE: MNKD), focused on the discovery and development of therapeutic products for diabetes, will present on Thursday, January 12, 2017 at the 35th Annual J.P. Morgan Healthcare Conference at 10:00 AM (PST) at the Westin St. Francis Hotel in San Francisco, California. 

Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.    

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind CorporationMannKind Corporation (Nasdaq: MNKD) (TASE: MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Company Contact:
Rose Alinaya
SVP Finance
661-775-5300
[email protected]

You May Also Be Interested In

• Vaxxinity, Inc (VAXX) to Voluntarily Delist
• Crown Castle (CCI) Issues Statement on "Ted Miller's Latest Attempt to Disrupt the Company's Momentum"
• Trump Media & Technology Group (DJT) send letter to Nasdaq over “naked” short selling